IBI3014 is a bispecific ADC targeting TROP2 and PD-L1. Its dual mechanism integrates TROP2-directed tumor killing with PD-L1 ...

SAN FRANCISCO and SUZHOU, China, April 28, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

Q1 2025 net product revenue of $137.8 million, representing 75% year-over-year growth -- ARCALYST 2025 expected net product revenue increased to $590 - $605 million -- KPL-387 ...

Tonix Pharmaceuticals Holding Corp.’s TNXP share price has surged by 7.99%, which has investors questioning if this is right ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

FC Barcelona Global Partner Human Mobile Devices (HMD) have launched their Barça-inspired telephones: the HMD Barça 3210 and the HMD Barça Fusion. Two handsets that combine football heritage ...

TNX-1700 is in preclinical development for gastric and colorectal cancers ...

Asset: Preclinical monoclonal antibodies for targeted tumor therapies • Deal Value: $19 million upfront; up to $585 million in milestones • Details: AstraZeneca entered into a global license ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...

The results of the STELLAR trial showed that the activin receptor type IIA-Fc (ActRIIA-Fc) fusion protein achieved a significant increase in exercise capacity measured using the six-minute walking ...